Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Current Leases: 2023-2025

Historic Current Leases for Inhibrx Biosciences (INBX) over the last 2 years, with Sep 2025 value amounting to $2.2 million.

  • Inhibrx Biosciences' Current Leases rose 22.45% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 22.45%. This contributed to the annual value of $1.6 million for FY2024, which is 22.69% down from last year.
  • According to the latest figures from Q3 2025, Inhibrx Biosciences' Current Leases is $2.2 million, which was up 3.60% from $2.2 million recorded in Q2 2025.
  • Inhibrx Biosciences' 5-year Current Leases high stood at $2.2 million for Q3 2025, and its period low was $1.6 million during Q4 2024.
  • Moreover, its 3-year median value for Current Leases was $2.1 million (2023), whereas its average is $2.0 million.
  • As far as peak fluctuations go, Inhibrx Biosciences' Current Leases fell by 22.69% in 2024, and later grew by 22.45% in 2025.
  • Quarterly analysis of 3 years shows Inhibrx Biosciences' Current Leases stood at $2.1 million in 2023, then dropped by 22.69% to $1.6 million in 2024, then increased by 22.45% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.2 million for Q2 2025, and $2.0 million during Q1 2025.